Reviva Pharmaceuticals Holdings Inc [RVPH] stock is trading at $0.53, up 3.14%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The RVPH shares have gain 9.40% over the last week, with a monthly amount drifted -21.75%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Reviva Pharmaceuticals Holdings Inc [NASDAQ: RVPH] stock has seen the most recent analyst activity on September 29, 2025, when Chardan Capital Markets initiated its Buy rating and assigned the stock a price target of $2. Previously, ROTH MKM started tracking the stock with Buy rating on September 20, 2023, and set its price target to $12. On June 08, 2023, The Benchmark Company initiated with a Speculative Buy rating and assigned a price target of $17 on the stock. H.C. Wainwright started tracking the stock assigning a Buy rating and suggested a price target of $10 on January 24, 2022.
Reviva Pharmaceuticals Holdings Inc [RVPH] stock has fluctuated between $0.25 and $4.28 over the past year. Reviva Pharmaceuticals Holdings Inc [NASDAQ: RVPH] shares were valued at $0.53 at the most recent close of the market.
Analyzing the RVPH fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -2.33, Equity is 7.7 and Total Capital is 61.83. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of-0.25.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.5080 points at the first support level, and at 0.4875 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.5424, and for the 2nd resistance point, it is at 0.5563.
Ratios To Look Out For
For context, Reviva Pharmaceuticals Holdings Inc’s Current Ratio is 1.39. Further, the Quick Ratio stands at 1.39, while the Cash Ratio is 0.86.
